2026年第一季度营收同比增长79%至2.16亿美元,主要得益于分子分析服务85%的增长;毛利率从47%提升至65%。 每股收益(EPS)为0美元,超出市场预期的每股亏损0.12美元100%;实现连续第四个季度调整后EBITDA为正,达到2600万美元,并产生2350万美元自由现金流。 尽管财报表现强劲,但盘后股价仍大跌15.58%至16.15美元,年初至今累计下跌46%,目前交投于52周低点附近 ...
BEIJING, May 18 (Xinhua) -- General Secretary of the Communist Party of China (CPC) Central Committee Xi Jinping has urged accelerated efforts in building up China's knowledge system in philosophy and ...
This clinical-stage biotech develops innovative retinal disease therapies, with its lead candidate advancing through ...
Chinese President Xi Jinping has stressed accelerating the building of a Chinese intellectual system in philosophy and social ...
WASHINGTON — The National Academies of Sciences, Engineering, and Medicine’s New Voices in Sciences, Engineering, and Medicine program has announced its 2026-2028 cohort of members, a group of 20 ...
立足香港,放眼世界。新浪财经全球资本峰会金曜奖投票启动!挖掘最具价值的资本力量,你的一票,至关重要 点击投票 周四,Conexeu Sciences(CNXU.US)登陆美股市场,开盘股价跌超3.6%,报13.01美元。IPO价格为13.5美元。Conexeu Sciences是一家美国早期医疗科技公司,专注于开发基于胶原蛋白的再生医学材料,主要用于伤口修复、牙科软组织修复以及医美领域。公司总部位 ...
Uncertainty is a defining feature of the modern world—from climate change and pandemics to financial instability, cybersecurity threats, and disruptive technologies. In a new article published in Risk ...
Awakn Life Sciences (AWKN) (ISIN: CA05455W1086)股票专题,提供今日Awakn Life Sciences(AWKN) (ISIN: CA05455W1086)股票最新股价查询,实时市场行情,走势图表,及Awakn Life Sciences Corp(AWKN) (ISIN: CA05455W1086)股票的专业技术分析,投资者论坛,历史交易数据,最新 ...